Long-term survival after sleeve lobectomy versus pneumonectomy for non-small cell lung cancer: a systematic review and meta-analysis

Abstract Background Sleeve lobectomy (SL) preserves lung parenchyma in selected patients with centrally located non-small cell lung cancer (NSCLC). We updated the comparative evidence on SL versus pneumonectomy (PN), focusing on long-term survival and perioperative outcomes. Methods PubMed, Embase, and the Cochrane Library were searched to June 10, 2025, for studies comparing SL with PN. Individual observations were reconstructed from published Kaplan–Meier curves with study identifiers retained. Study-specific hazard ratios (HRs) were pooled using restricted maximum likelihood (REML) with modified Hartung–Knapp confidence intervals, and a study-stratified Cox model was fitted as a complementary analysis. Perioperative outcomes were pooled with the same random-effects approach. Results Twenty-seven studies were included, of which 25 contributed to the meta-analysis. SL was associated with better overall survival (OS; 19 studies, 5,491 patients; HR 0.62, 95% CI 0.55–0.70) and disease-free survival (DFS; seven studies, 3,675 patients; HR 0.70, 95% CI 0.61–0.81), and with lower 30-day (OR 0.54, 95% CI 0.31–0.92) and 90-day mortality (OR 0.36, 95% CI 0.17–0.77). Bronchopleural fistula, reoperation, and hospital stay did not differ significantly. The OS association persisted among matched cohorts (HR 0.62, 95% CI 0.52–0.75), whereas pooled source-reported multivariable estimates were less precise (HR 0.70, 95% CI 0.48–1.03). Conclusions In observational cohorts, SL was associated with better long-term survival and lower early mortality than PN. Residual confounding by indication precludes causal inference, but the findings support parenchyma-preserving sleeve resection when an R0 resection is technically and oncologically feasible.

Authors

Institutions

Publication Details

Journal
Journal of Cardiothoracic Surgery
Published
2026-11-17
DOI
https://doi.org/10.1186/s13019-026-04799-y
Primary Topic
Lung Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Long-term survival after sleeve lobectomy versus pneumonectomy for non-small cell lung cancer: a systematic review and meta-analysis

Lucas Monteiro Delgado, Isabella Cabianca Moriguchi Caetano Salvador, Juliana Giorgi, Felipe Santos Passos et al.
2 links
Journal of Cardiothoracic Surgery
Lung Cancer Diagnosis and Treatment
article

Long-term survival after sleeve lobectomy versus pneumonectomy for non-small cell lung cancer: a systematic review and meta-analysis

Lucas Monteiro Delgado, Isabella Cabianca Moriguchi Caetano Salvador, Juliana Giorgi, Felipe Santos Passos, Deepti Sreepathi, Rachid Eduardo Noleto da Nobrega Oliveira, Muhammad Younas, Adriana Simoneta Pimienta Ibarra, Paula Duarte D. Ambrosio, Túlio Caldonazo, Paula A. Ugalde
article en

Abstract

Abstract Background Sleeve lobectomy (SL) preserves lung parenchyma in selected patients with centrally located non-small cell lung cancer (NSCLC). We updated the comparative evidence on SL versus pneumonectomy (PN), focusing on long-term survival and perioperative outcomes. Methods PubMed, Embase, and the Cochrane Library were searched to June 10, 2025, for studies comparing SL with PN. Individual observations were reconstructed from published Kaplan–Meier curves with study identifiers retained. Study-specific hazard ratios (HRs) were pooled using restricted maximum likelihood (REML) with modified Hartung–Knapp confidence intervals, and a study-stratified Cox model was fitted as a complementary analysis. Perioperative outcomes were pooled with the same random-effects approach. Results Twenty-seven studies were included, of which 25 contributed to the meta-analysis. SL was associated with better overall survival (OS; 19 studies, 5,491 patients; HR 0.62, 95% CI 0.55–0.70) and disease-free survival (DFS; seven studies, 3,675 patients; HR 0.70, 95% CI 0.61–0.81), and with lower 30-day (OR 0.54, 95% CI 0.31–0.92) and 90-day mortality (OR 0.36, 95% CI 0.17–0.77). Bronchopleural fistula, reoperation, and hospital stay did not differ significantly. The OS association persisted among matched cohorts (HR 0.62, 95% CI 0.52–0.75), whereas pooled source-reported multivariable estimates were less precise (HR 0.70, 95% CI 0.48–1.03). Conclusions In observational cohorts, SL was associated with better long-term survival and lower early mortality than PN. Residual confounding by indication precludes causal inference, but the findings support parenchyma-preserving sleeve resection when an R0 resection is technically and oncologically feasible.

Journal of Cardiothoracic Surgery
Universidade Federal de Minas Gerais (BR), Brigham and Women's Hospital (US), Gomal University (PK), Universidade de São Paulo (BR), Anhembi Morumbi University (BR), Hospital de Câncer de Barretos (BR), Instituto Nacional de Enfermedades Respiratorias (MX), Dana-Farber Cancer Institute (US), Jena University Hospital (DE), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR), Hospital Sírio-Libanês (BR), Dana-Farber Brigham Cancer Center (US), Weill Cornell Medicine (US), Friedrich Schiller University Jena (DE)
Friedrich-Schiller-Universität Jena, Deutsche Forschungsgemeinschaft, Deutsche Herzstiftung
Good health and well-being
Lung Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon